Home > Healthcare > Medical Devices > Diagnostic Devices > Cancer Diagnostics Market

Cancer Diagnostics Market Share

Report ID: GMI2406
Published Date: Jan 2023
Report Format: PDF

Download Free Sample

Cancer Diagnostics Market Share

Some of the leading companies in the global cancer diagnostics market include

Agilent Technologies Inc
Abbott Laboratories
Becton
Dickinson and Company
AB Sciex Pte. Ltd
Biocare Medical LLC
BioMerieux SA
Biocartis
Bio-Rad Laboratories
GE Healthcare
Janssen Diagnostics LLC (Johnson & Johnson)
Cancer Genetics Inc
Hologic Inc
Leica Biosystem Nussloch GmbH (Danaher Corporation)
Qiagen N.V
F-Hoffmann-La Roche Ltd
Myriad Genetics, Inc
Siemens Healthineers
Thermo Fischer Scientific
Sysmex Corporation

These firms are developing advanced products with superior performance capabilities for better consumer traction.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for cancer diagnostics was worth more than USD 136 billion in 2022 and is projected to exhibit over 9% CAGR from 2023-2032.

Non-Hodgkin lymphoma (NHL) is estimated to reach over USD 18.5 billion by 2032 due to increasing prevalence in the aging population.

Europe cancer diagnostics market size is slated to surpass USD 93.5 billion by 2032 owing to the presence of growing healthcare expenditure and supportive initiatives.

Abbott Laboratories, BioMerieux SA, Biocartis, Hologic Inc, Qiagen N.V, Myriad Genetics, Inc, and Sysmex Corporation are some key participants in the market.